Lemonade, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Lemonade, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $737.90M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $526.50M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $429.80M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $256.70M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $128.40M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $94.40M | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | $67.30M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $22.50M | Mar 8, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($165.50M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($202.20M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | ($236.90M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | ($297.80M) | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | ($241.30M) | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | ($122.30M) | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | ($108.50M) | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | ($52.90M) | Mar 8, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $93.90M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $85.80M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $88.80M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $79.60M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $51.80M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $19.40M | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | $9.80M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $4.70M | Mar 8, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($16.50M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($11.40M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | ($119.10M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | ($163.00M) | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | ($144.60M) | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | ($91.70M) | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | ($78.10M) | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | ($40.80M) | Mar 8, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.40M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $9.40M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $9.20M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $10.10M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $9.40M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $4.40M | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | $2.70M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $700.0K | Mar 8, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.93B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.85B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $1.63B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $1.69B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.51B | Mar 3, 2023 |
| FY2021 | Dec 31, 2020 | $828.70M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $414.30M | Mar 8, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.39B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.26B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $924.40M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $823.90M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $522.30M | Mar 3, 2023 |
| FY2021 | Dec 31, 2020 | $287.70M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $116.60M | Mar 8, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $533.60M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $593.40M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $708.90M | Feb 25, 2026 |
| FY2025 | Dec 31, 2022 | $866.80M | Feb 25, 2026 |
| FY2024 | Dec 31, 2021 | $988.20M | Feb 26, 2025 |
| FY2023 | Dec 31, 2020 | $541.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2019 | ($182.50M) | Mar 3, 2023 |
| FY2021 | Dec 31, 2018 | ($79.10M) | Mar 1, 2022 |
| FY2020 | Dec 31, 2017 | ($28.40M) | Mar 8, 2021 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $19.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $19.00M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $19.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $0 | Mar 3, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.46B) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($1.30B) | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | ($1.10B) | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | ($859.70M) | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | ($561.90M) | Mar 3, 2023 |
| FY2021 | Dec 31, 2020 | ($320.60M) | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | ($198.30M) | Mar 8, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $385.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $376.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $264.50M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $282.50M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $270.60M | Mar 3, 2023 |
| FY2021 | Dec 31, 2020 | $570.80M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $270.00M | Mar 8, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | (2) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | (3) | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | (4) | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | (3) | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | (3) | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | (9) | Mar 1, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | (2) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | (3) | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | (4) | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | (3) | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | (3) | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | (9) | Mar 1, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 75.91M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 72.72M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | 70.16M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | 69.28M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 61.66M | Mar 3, 2023 |
| FY2021 | Dec 31, 2020 | 56.77M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | 11.27M | Mar 8, 2021 |